AbCellera Biologics Inc. (FRA:8QQ)
Germany · Delayed Price · Currency is EUR 3.250
+0.144 (4.64%)
At close: Nov 28, 2025
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of €893.48 million as of December 2, 2025. Its market cap has increased by 8.43% in one year.
Market Cap
893.48M
Enterprise Value
589.44M
Revenue
30.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.25
Market Cap Chart
Since December 11, 2020, AbCellera Biologics's market cap has decreased from 12.93B to 893.48M, a decrease of -93.09%. That is a compound annual growth rate of -41.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 962.89M | 15.19% |
| Dec 31, 2024 | 835.91M | -44.23% |
| Dec 29, 2023 | 1.50B | -44.72% |
| Dec 30, 2022 | 2.71B | -23.41% |
| Dec 31, 2021 | 3.54B | -60.02% |
| Dec 31, 2020 | 8.86B | -31.53% |
| Dec 11, 2020 | 12.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |